AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 12,751 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 6, 2026 · Filed Nov 9, 2026

On Nov 6, 2026, Equels Thomas K (Director, CEO & President) bought 12,751 AIM ImmunoTech Inc. shares at US$0.16 for US$2,015, leaving 222,797 shares. Filed Nov 9, 2026 (Form 4).

Bought
12,751 shares
Price
US$0.16
Value
US$2,015
Holding after
222,797 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 6, 2026Common StockBuy12,751US$0.16222,797Direct

Source

Download original · View original at SEC

Related